Sinn HP - Search Results

1

Only grading has independent impact on breast cancer survival after adjustment for pathological response to preoperative chemotherapy.

Schneeweiss A, Katretchko J, Sinn HP, Unnebrink K, Rudlowski C, Geberth M, Beldermann F, Bastert G, Strittmatter HJ. Schneeweiss A, et al. Among authors: sinn hp. Anticancer Drugs. 2004 Feb;15(2):127-35. doi: 10.1097/00001813-200402000-00005. Anticancer Drugs. 2004. PMID: 15075668

2

CD44 variant exon epitopes in primary breast cancer and length of survival.

Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P. Kaufmann M, et al. Among authors: sinn hp. Lancet. 1995 Mar 11;345(8950):615-9. doi: 10.1016/s0140-6736(95)90521-9. Lancet. 1995. PMID: 7534855

3

[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy].

Sinn HP, Schmid H, Junkermann H, Huober J, Leppien G, Kaufmann M, Bastert G, Otto HF. Sinn HP, et al. Geburtshilfe Frauenheilkd. 1994 Oct;54(10):552-8. doi: 10.1055/s-2007-1022338. Geburtshilfe Frauenheilkd. 1994. PMID: 8001751 German.

4

[DNA cytometry in breast carcinoma. Review of method and value in assessing prognosis].

Sinn HP, Haag D, Ehemann V, Magener A, Goerttler K, Bastert G, Otto HF. Sinn HP, et al. Pathologe. 1997 Jan;18(1):19-26. doi: 10.1007/s002920050192. Pathologe. 1997. PMID: 9157400 Review. German.

5

[Subtyping and prognostic assessment of invasive lobular breast carcinoma].

Sinn HP, Kellerhoff NM, Kellerhoff R, Bastert G, Otto HF. Sinn HP, et al. Pathologe. 1997 Jan;18(1):37-44. doi: 10.1007/s002920050194. Pathologe. 1997. PMID: 9157403 German.

6

[Complete remission after salvage chemotherapy in metastatic breast carcinoma after failure of induction cycles of planned high dosage chemotherapy with stem cell support].

Solomayer EF, Diel IJ, Meyberg G, Sinn HP, Emig R, Wallwiener D, Bastert G. Solomayer EF, et al. Among authors: sinn hp. Zentralbl Gynakol. 1998;120(7):337-40. Zentralbl Gynakol. 1998. PMID: 9703656 German.

7

Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy.

Sinn HP, Anton HW, Magener A, von Fournier D, Bastert G, Otto HF. Sinn HP, et al. Eur J Cancer. 1998 Apr;34(5):646-53. doi: 10.1016/s0959-8049(97)10106-x. Eur J Cancer. 1998. PMID: 9713268

8

Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma.

Schilling T, Bürck J, Sinn HP, Clemens A, Otto HF, Höppner W, Herfarth C, Ziegler R, Schwab M, Raue F. Schilling T, et al. Among authors: sinn hp. Int J Cancer. 2001 Jan 20;95(1):62-6. doi: 10.1002/1097-0215(20010120)95:1<62::aid-ijc1011>3.0.co;2-1. Int J Cancer. 2001. PMID: 11241313

9

A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery.

Huber PE, Jenne JW, Rastert R, Simiantonakis I, Sinn HP, Strittmatter HJ, von Fournier D, Wannenmacher MF, Debus J. Huber PE, et al. Among authors: sinn hp. Cancer Res. 2001 Dec 1;61(23):8441-7. Cancer Res. 2001. PMID: 11731425

10

Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support.

Hensel M, Schneeweiss A, Sinn HP, Egerer G, Kornacker M, Solomayer E, Haas R, Bastert G, Ho AD. Hensel M, et al. Among authors: sinn hp. Stem Cells. 2002;20(1):32-40. doi: 10.1634/stemcells.20-1-32. Stem Cells. 2002. PMID: 11796920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters